An assessment of the thyroid cytopathology reporting system used in Bethesda

Ultrasound may identify thyroid nodules in up to 60% of the general population, which is a frequent condition. The increased diagnosis of tiny papillary carcinomas is most likely to blame for the global rise in differentiated thyroid cancer prevalence, according to data from the Surveillance Epidemiology and End Results (SEER) registry. Thyroid Fine-Needle Aspiration (FNA) has shown to be a quick, affordable, safe, and reliable form of inquiry for the first examination of individuals with such lesions. Additionally, this treatment is the best diagnostic tool for determining if a patient needs clinical therapy or surgical excision. An increase in cytological diagnostic methods has been caused by the rising incidence of thyroid cancer and advancements in the technology and resolution of ultrasound equipment.